Stephens Inc’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $388K | Buy |
4,954
+397
| +9% | +$27.1K | ﹤0.01% | 979 |
|
|
2026
Q1 | $295K | Buy |
4,557
+495
| +12% | +$34.9K | ﹤0.01% | 1048 |
|
|
2025
Q4 | $273K | Sell |
4,062
-95
| -2% | -$6.39K | ﹤0.01% | 1079 |
|
|
2025
Q3 | $305K | Sell |
4,157
-1,050
| -20% | -$69.7K | ﹤0.01% | 1041 |
|
|
2025
Q2 | $271K | Sell |
5,207
-244
| -4% | -$13.9K | ﹤0.01% | 1059 |
|
|
2025
Q1 | $348K | Sell |
5,451
-13
| -0.2% | -$755 | 0.01% | 934 |
|
|
2024
Q4 | $261K | Sell |
5,464
-1,377
| -20% | -$70.6K | ﹤0.01% | 1069 |
|
|
2024
Q3 | $392K | Sell |
6,841
-2,342
| -26% | -$134K | 0.01% | 926 |
|
|
2024
Q2 | $481K | Sell |
9,183
-36
| -0.4% | -$1.58K | 0.01% | 818 |
|
|
2024
Q1 | $375K | Buy |
9,219
+2,930
| +47% | +$110K | 0.01% | 930 |
|
|
2023
Q4 | $232K | Buy |
6,289
+159
| +3% | +$5.99K | ﹤0.01% | 1025 |
|
|
2023
Q3 | $234K | Buy |
6,130
+255
| +4% | +$10.4K | ﹤0.01% | 982 |
|
|
2023
Q2 | $212K | Buy |
5,875
+2,953
| +101% | +$101K | ﹤0.01% | 1042 |
|
|
2023
Q1 | $112K | Buy |
2,922
+23
| +0.8% | +$1.08K | ﹤0.01% | 1085 |
|
|
2022
Q4 | $165K | Hold |
2,899
| – | – | ﹤0.01% | 1030 |
|
|
2022
Q3 | $115K | Hold |
2,899
| – | – | ﹤0.01% | 1084 |
|
|
2022
Q2 | $128K | Hold |
2,899
| – | – | ﹤0.01% | 1115 |
|
|
2022
Q1 | $116K | Buy |
2,899
+369
| +15% | +$13.1K | ﹤0.01% | 1217 |
|
|
2021
Q4 | $102K | Hold |
2,530
| – | – | ﹤0.01% | 1258 |
|
|
2021
Q3 | $103K | Hold |
2,530
| – | – | ﹤0.01% | 1267 |
|
|
2021
Q2 | $115K | Hold |
2,530
| – | – | ﹤0.01% | 1254 |
|
|
2021
Q1 | $105K | Buy |
2,530
+2,000
| +377% | +$91.3K | ﹤0.01% | 1220 |
|
|
2020
Q4 | $23K | Sell |
530
-2,603
| -83% | -$93.6K | ﹤0.01% | 1183 |
|
|
2020
Q3 | $82K | Sell |
3,133
-867
| -22% | -$24.1K | ﹤0.01% | 1106 |
|
|
2020
Q2 | $107K | Buy |
+4,000
| New | +$90.2K | ﹤0.01% | 1044 |
|
|
2017
Q2 | – | Sell |
-11,000
| Closed | -$143K | – | 880 |
|
|
2017
Q1 | $143K | Hold |
11,000
| – | – | 0.01% | 787 |
|
|
2016
Q4 | $109K | Hold |
11,000
| – | – | ﹤0.01% | 744 |
|
|
2016
Q3 | $133K | Hold |
11,000
| – | – | 0.01% | 718 |
|
|
2016
Q2 | $95K | Hold |
11,000
| – | – | ﹤0.01% | 712 |
|
|
2016
Q1 | $104K | Hold |
11,000
| – | – | 0.01% | 696 |
|
|
2015
Q4 | $191K | Hold |
11,000
| – | – | 0.01% | 658 |
|
|
2015
Q3 | $148K | Hold |
11,000
| – | – | 0.01% | 672 |
|
|
2015
Q2 | $248K | Hold |
11,000
| – | – | 0.01% | 653 |
|
|
2015
Q1 | $157K | Sell |
11,000
-2,000
| -15% | -$28.8K | 0.01% | 739 |
|
|
2014
Q4 | $125K | Hold |
13,000
| – | – | 0.01% | 744 |
|
|
2014
Q3 | $118K | Buy |
+13,000
| New | +$124K | 0.01% | 744 |
|
Other funds holding HALO
Stephens Inc's HALO Position: Q2 2026 in Review
Stephens Inc increased its Halozyme (HALO) stake by 8.7% in Q2 2026, buying an estimated $27.1K and bringing the position to 4,954 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #979.
Stephens Inc first reported a position in HALO in Q3 2014 and has held it in 36 quarters since. The position peaked at $481K in Q2 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Stephens Inc held 4,954 shares of Halozyme worth $388K as of Q2 2026.
- Stephens Inc bought 397 Halozyme shares in Q2 2026, an estimated $27.1K.
- Halozyme made up ﹤0.01% of Stephens Inc's portfolio in Q2 2026, its #979 holding.
- Stephens Inc first reported a position in Halozyme in Q3 2014 and has held it in 36 quarters since.
- Stephens Inc's Halozyme position peaked at $481K in Q2 2024.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.